News

biote Corp. (BTMD) Q1 2024 Earnings Call Transcript

biote Corp. (NASDAQ:BTMD ) Q1 2024 Earnings Conference Call May 7, 2024 5:00 PM ET Company Participants Simon Serowiecki - Investor Relations Terry Weber - Chief Executive Officer Bob Peterson - Chief Financial Officer Marc Beer - Executive Chairman Ross McQuivey - Chief Medical Officer Conference Call Participants Les Sulewski - Truist Securities Jonna Kim - TD Cowen Kaumil Gajrawala - Jefferies George Kelly - ROTH MKM Operator Good day, and welcome to the Biote First Quarter 2024 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.

05/09/2024

Biote Corp. (BTMD) Q1 Earnings Beat Estimates

Biote Corp. (BTMD) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.94 per share a year ago.

05/07/2024

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is Haymaker Acquisition Corp. III (BTMD) a buy, sell, or hold?

Haymaker Acquisition Corp. III (BTMD) can sell. Click on Rating Page for detail.

What is Haymaker Acquisition Corp. III's stock price?

The price of Haymaker Acquisition Corp. III (BTMD) is 5.75 and it was updated on 2024-05-18 07:01:13.

Is Haymaker Acquisition Corp. III (BTMD) overvalued or undervalued?

Currently Haymaker Acquisition Corp. III (BTMD) is in overvalued.

News

From:

To:

News
Biote Reports First Quarter 2024 Financial Results IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Highlights (All financial result comparisons made are against the prior-year period) Revenue of $46.8 million, up 4.4% Procedure revenue of $37.4 million, up 6.6% Gross profit margin of 71.4%, an app. Tue, May. 07, 2024
Earnings Preview: biote Corp. (BTMD) Q1 Earnings Expected to Decline Biote Corp. (BTMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Tue, Apr. 30, 2024
Biote Announces Definitive Settlement with Founder IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced it has entered into a definitive settlement agreement (the “Settlement Agreement”) that concludes outstanding litigation with Dr. Gary S. Donovitz (“Donovitz”), founder and stockholder of Biote. The Settlement Agreement includes a mutual release of all clai. Mon, Apr. 29, 2024
Biote Schedules First Quarter 2024 Financial Results Release and Conference Call IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the Company will provide first quarter financial results on Tuesday, May 7, 2024, after the close of the market. A conference call to discuss the firm's results will be held at 5:00 p.m. ET. the same day. Conference Call Details The conference call may be a. Tue, Apr. 23, 2024
This overlooked corner of women's health could be a $350 billion market opportunity Menopause is among the female health conditions with the highest unmet need and has 'enormous potential for innovative treatments,' according to McKinsey. Fri, Mar. 15, 2024

Transcripts

Transcipts Data
Haymaker Acquisition Corp. III (BTMD) on Q1 2024 Results - Earnings Call Transcript SA Transcripts Tue, May. 07, 2024
Haymaker Acquisition Corp. III (BTMD) on Q4 2023 Results - Earnings Call Transcript SA Transcripts Tue, Mar. 12, 2024
Haymaker Acquisition Corp. III (BTMD) on Q3 2023 Results - Earnings Call Transcript SA Transcripts Wed, Nov. 08, 2023
Haymaker Acquisition Corp. III (BTMD) on Q2 2023 Results - Earnings Call Transcript SA Transcripts Fri, Aug. 11, 2023

SEC Filings

SEC Filings
Haymaker Acquisition Corp. III (BTMD) - 424B3 SEC Filings 05/10/2024
Haymaker Acquisition Corp. III (BTMD) - 10-Q - Quarterly Report SEC Filings 05/10/2024
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 05/07/2024
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 04/29/2024
Haymaker Acquisition Corp. III (BTMD) - DEFA14A SEC Filings 04/11/2024
Haymaker Acquisition Corp. III (BTMD) - DEF 14A SEC Filings 04/11/2024
Haymaker Acquisition Corp. III (BTMD) - ARS SEC Filings 04/11/2024
Haymaker Acquisition Corp. III (BTMD) - 424B3 SEC Filings 04/09/2024
Haymaker Acquisition Corp. III (BTMD) - EFFECT SEC Filings 04/03/2024
Haymaker Acquisition Corp. III (BTMD) - EFFECT SEC Filings 04/03/2024
Haymaker Acquisition Corp. III (BTMD) - S-8 SEC Filings 04/03/2024
Haymaker Acquisition Corp. III (BTMD) - 4 SEC Filings 04/03/2024
Haymaker Acquisition Corp. III (BTMD) - POS AM SEC Filings 04/01/2024
Haymaker Acquisition Corp. III (BTMD) - 10-K - Current report SEC Filings 03/15/2024
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 03/14/2024
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 03/12/2024
Haymaker Acquisition Corp. III (BTMD) - 424B3 SEC Filings 02/21/2024
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 02/20/2024
Haymaker Acquisition Corp. III (BTMD) - SC 13G/A SEC Filings 02/14/2024
Haymaker Acquisition Corp. III (BTMD) - SC 13G/A SEC Filings 02/13/2024
Haymaker Acquisition Corp. III (BTMD) - SC 13G/A SEC Filings 02/12/2024
Haymaker Acquisition Corp. III (BTMD) - 4 SEC Filings 02/05/2024
Haymaker Acquisition Corp. III (BTMD) - 3 SEC Filings 01/31/2024
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 01/25/2024
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 01/17/2024
Haymaker Acquisition Corp. III (BTMD) - 424B3 SEC Filings 01/17/2024
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 01/11/2024
Haymaker Acquisition Corp. III (BTMD) - 424B3 SEC Filings 11/14/2023
Haymaker Acquisition Corp. III (BTMD) - 10-Q - Quarterly Report SEC Filings 11/13/2023
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 11/07/2023
Haymaker Acquisition Corp. III (BTMD) - 424B3 SEC Filings 08/11/2023
Haymaker Acquisition Corp. III (BTMD) - 10-Q - Quarterly Report SEC Filings 08/11/2023
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 08/10/2023
Haymaker Acquisition Corp. III (BTMD) - 25-NSE SEC Filings 07/07/2023
Haymaker Acquisition Corp. III (BTMD) - 4 SEC Filings 07/06/2023
Haymaker Acquisition Corp. III (BTMD) - 4 SEC Filings 07/05/2023
Haymaker Acquisition Corp. III (BTMD) - SC 13G/A SEC Filings 06/23/2023
Haymaker Acquisition Corp. III (BTMD) - 4 SEC Filings 06/23/2023
Haymaker Acquisition Corp. III (BTMD) - SC 13D SEC Filings 06/15/2023
Haymaker Acquisition Corp. III (BTMD) - 3 SEC Filings 06/15/2023
Haymaker Acquisition Corp. III (BTMD) - SC 13G SEC Filings 06/13/2023
Haymaker Acquisition Corp. III (BTMD) - SC TO-I/A SEC Filings 06/09/2023
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 06/09/2023
Haymaker Acquisition Corp. III (BTMD) - 425 SEC Filings 06/09/2023
Haymaker Acquisition Corp. III (BTMD) - 424B3 SEC Filings 06/09/2023
Haymaker Acquisition Corp. III (BTMD) - EFFECT SEC Filings 06/08/2023
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 06/07/2023
Haymaker Acquisition Corp. III (BTMD) - 424B3 SEC Filings 06/07/2023
Haymaker Acquisition Corp. III (BTMD) - 4 SEC Filings 06/02/2023
Haymaker Acquisition Corp. III (BTMD) - 3 SEC Filings 06/02/2023
Haymaker Acquisition Corp. III (BTMD) - S-4/A SEC Filings 05/23/2023
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 05/19/2023
Haymaker Acquisition Corp. III (BTMD) - 4 SEC Filings 05/19/2023
Haymaker Acquisition Corp. III (BTMD) - S-4/A SEC Filings 05/16/2023
Haymaker Acquisition Corp. III (BTMD) - 424B3 SEC Filings 05/16/2023
Haymaker Acquisition Corp. III (BTMD) - DEL AM SEC Filings 05/15/2023
Haymaker Acquisition Corp. III (BTMD) - 10-Q - Quarterly Report SEC Filings 05/12/2023
Haymaker Acquisition Corp. III (BTMD) - 425 SEC Filings 05/10/2023
Haymaker Acquisition Corp. III (BTMD) - 424B3 SEC Filings 05/10/2023
Haymaker Acquisition Corp. III (BTMD) - SC TO-I SEC Filings 05/09/2023
Haymaker Acquisition Corp. III (BTMD) - S-4 SEC Filings 05/09/2023
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 05/09/2023
Haymaker Acquisition Corp. III (BTMD) - S-8 SEC Filings 04/24/2023
Haymaker Acquisition Corp. III (BTMD) - DEF 14A SEC Filings 04/14/2023
Haymaker Acquisition Corp. III (BTMD) - ARS SEC Filings 04/14/2023
Haymaker Acquisition Corp. III (BTMD) - 424B3 SEC Filings 04/13/2023
Haymaker Acquisition Corp. III (BTMD) - EFFECT SEC Filings 04/12/2023
Haymaker Acquisition Corp. III (BTMD) - EFFECT SEC Filings 04/12/2023
Haymaker Acquisition Corp. III (BTMD) - POS AM SEC Filings 04/06/2023
Haymaker Acquisition Corp. III (BTMD) - 4 SEC Filings 04/06/2023
Haymaker Acquisition Corp. III (BTMD) - 4 SEC Filings 04/05/2023
Haymaker Acquisition Corp. III (BTMD) - 4 SEC Filings 04/04/2023
Haymaker Acquisition Corp. III (BTMD) - 424B3 SEC Filings 03/30/2023
Haymaker Acquisition Corp. III (BTMD) - 10-Q/A - Quarterly Report SEC Filings 03/29/2023
Haymaker Acquisition Corp. III (BTMD) - 10-K - Current report SEC Filings 03/29/2023
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 03/28/2023
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 03/24/2023
Haymaker Acquisition Corp. III (BTMD) - 424B3 SEC Filings 03/24/2023
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 02/22/2023
Haymaker Acquisition Corp. III (BTMD) - SC 13G SEC Filings 02/17/2023
Haymaker Acquisition Corp. III (BTMD) - 4 SEC Filings 02/17/2023
Haymaker Acquisition Corp. III (BTMD) - 3 SEC Filings 02/17/2023
Haymaker Acquisition Corp. III (BTMD) - SC 13G/A SEC Filings 02/14/2023
Haymaker Acquisition Corp. III (BTMD) - SC 13G SEC Filings 02/07/2023
Haymaker Acquisition Corp. III (BTMD) - SC 13G/A SEC Filings 02/03/2023
Haymaker Acquisition Corp. III (BTMD) - 4 SEC Filings 01/10/2023
Haymaker Acquisition Corp. III (BTMD) - 424B4 SEC Filings 01/06/2023
Haymaker Acquisition Corp. III (BTMD) - EFFECT SEC Filings 01/05/2023
Haymaker Acquisition Corp. III (BTMD) - 4 SEC Filings 01/04/2023
Haymaker Acquisition Corp. III (BTMD) - S-1/A SEC Filings 01/03/2023
Haymaker Acquisition Corp. III (BTMD) - 4 SEC Filings 12/13/2022
Haymaker Acquisition Corp. III (BTMD) - S-1 SEC Filings 12/12/2022
Haymaker Acquisition Corp. III (BTMD) - 4/A SEC Filings 11/18/2022
Haymaker Acquisition Corp. III (BTMD) - 4 SEC Filings 11/16/2022
Haymaker Acquisition Corp. III (BTMD) - 424B3 SEC Filings 11/14/2022
Haymaker Acquisition Corp. III (BTMD) - 10-Q - Quarterly Report SEC Filings 11/14/2022
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 11/08/2022
Haymaker Acquisition Corp. III (BTMD) - 3 SEC Filings 11/08/2022
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 11/07/2022
Haymaker Acquisition Corp. III (BTMD) - 424B3 SEC Filings 11/07/2022
Haymaker Acquisition Corp. III (BTMD) - SC 13G SEC Filings 10/12/2022
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 10/11/2022
Haymaker Acquisition Corp. III (BTMD) - 4/A SEC Filings 09/19/2022
Haymaker Acquisition Corp. III (BTMD) - 4 SEC Filings 09/19/2022
Haymaker Acquisition Corp. III (BTMD) - 3 SEC Filings 09/07/2022
Haymaker Acquisition Corp. III (BTMD) - CERT SEC Filings 08/26/2022
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 08/25/2022
Haymaker Acquisition Corp. III (BTMD) - 8-A12B SEC Filings 08/25/2022
Haymaker Acquisition Corp. III (BTMD) - 424B3 SEC Filings 08/25/2022
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 08/24/2022
Haymaker Acquisition Corp. III (BTMD) - 424B3 SEC Filings 08/24/2022
Haymaker Acquisition Corp. III (BTMD) - 424B3 SEC Filings 08/16/2022
Haymaker Acquisition Corp. III (BTMD) - 8-K/A - Current report SEC Filings 08/15/2022
Haymaker Acquisition Corp. III (BTMD) - 424B3 SEC Filings 08/15/2022
Haymaker Acquisition Corp. III (BTMD) - 10-Q - Quarterly Report SEC Filings 08/15/2022
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 08/10/2022
Haymaker Acquisition Corp. III (BTMD) - 424B3 SEC Filings 08/09/2022
Haymaker Acquisition Corp. III (BTMD) - EFFECT SEC Filings 08/08/2022
Haymaker Acquisition Corp. III (BTMD) - EFFECT SEC Filings 08/08/2022
Haymaker Acquisition Corp. III (BTMD) - 424B3 SEC Filings 08/08/2022
Haymaker Acquisition Corp. III (BTMD) - UPLOAD SEC Filings 08/03/2022
Haymaker Acquisition Corp. III (BTMD) - S-8 SEC Filings 08/03/2022
Haymaker Acquisition Corp. III (BTMD) - CORRESP SEC Filings 08/03/2022
Haymaker Acquisition Corp. III (BTMD) - S-1 SEC Filings 08/01/2022
Haymaker Acquisition Corp. III (BTMD) - S-1 SEC Filings 07/29/2022
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 07/28/2022
Haymaker Acquisition Corp. III (BTMD) - 424B3 SEC Filings 07/28/2022
Haymaker Acquisition Corp. III (BTMD) - 4 SEC Filings 07/21/2022
Haymaker Acquisition Corp. III (BTMD) - EFFECT SEC Filings 07/20/2022
Haymaker Acquisition Corp. III (BTMD) - EFFECT SEC Filings 07/20/2022
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 07/19/2022
Haymaker Acquisition Corp. III (BTMD) - 424B3 SEC Filings 07/19/2022
Haymaker Acquisition Corp. III (BTMD) - CORRESP SEC Filings 07/15/2022
Haymaker Acquisition Corp. III (BTMD) - S-1/A SEC Filings 07/11/2022
Haymaker Acquisition Corp. III (BTMD) - CORRESP SEC Filings 07/11/2022
Haymaker Acquisition Corp. III (BTMD) - UPLOAD SEC Filings 07/08/2022
Haymaker Acquisition Corp. III (BTMD) - S-1/A SEC Filings 06/28/2022
Haymaker Acquisition Corp. III (BTMD) - CORRESP SEC Filings 06/28/2022
Haymaker Acquisition Corp. III (BTMD) - UPLOAD SEC Filings 06/24/2022
Haymaker Acquisition Corp. III (BTMD) - S-1/A SEC Filings 06/22/2022
Haymaker Acquisition Corp. III (BTMD) - S-1 SEC Filings 06/17/2022
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 06/09/2022
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 06/02/2022
Haymaker Acquisition Corp. III (BTMD) - 4 SEC Filings 05/31/2022
Haymaker Acquisition Corp. III (BTMD) - 3 SEC Filings 05/31/2022
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 05/27/2022
Haymaker Acquisition Corp. III (BTMD) - 25-NSE SEC Filings 05/26/2022
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 05/25/2022
Haymaker Acquisition Corp. III (BTMD) - 10-Q - Quarterly Report SEC Filings 05/23/2022
Haymaker Acquisition Corp. III (BTMD) - DEFA14A SEC Filings 05/20/2022
Haymaker Acquisition Corp. III (BTMD) - DEFA14A SEC Filings 05/17/2022
Haymaker Acquisition Corp. III (BTMD) - NT 10-Q - Quarterly Report SEC Filings 05/16/2022
Haymaker Acquisition Corp. III (BTMD) - DEFA14A SEC Filings 05/11/2022
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 05/11/2022
Haymaker Acquisition Corp. III (BTMD) - DEFM14A SEC Filings 05/05/2022
Haymaker Acquisition Corp. III (BTMD) - UPLOAD SEC Filings 05/04/2022
Haymaker Acquisition Corp. III (BTMD) - 8-K/A - Current report SEC Filings 05/04/2022
Haymaker Acquisition Corp. III (BTMD) - SC 13G SEC Filings 04/29/2022
Haymaker Acquisition Corp. III (BTMD) - PRER14A SEC Filings 04/27/2022
Haymaker Acquisition Corp. III (BTMD) - CORRESP SEC Filings 04/27/2022
Haymaker Acquisition Corp. III (BTMD) - UPLOAD SEC Filings 04/20/2022
Haymaker Acquisition Corp. III (BTMD) - PRER14A SEC Filings 04/08/2022
Haymaker Acquisition Corp. III (BTMD) - CORRESP SEC Filings 04/08/2022
Haymaker Acquisition Corp. III (BTMD) - 10-K - Current report SEC Filings 04/07/2022
Haymaker Acquisition Corp. III (BTMD) - NT 10-K - Current report SEC Filings 04/01/2022
Haymaker Acquisition Corp. III (BTMD) - DEFA14A SEC Filings 03/30/2022
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 03/30/2022
Haymaker Acquisition Corp. III (BTMD) - UPLOAD SEC Filings 03/16/2022
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 03/04/2022
Haymaker Acquisition Corp. III (BTMD) - SC 13G SEC Filings 02/14/2022
Haymaker Acquisition Corp. III (BTMD) - SC 13G SEC Filings 02/11/2022
Haymaker Acquisition Corp. III (BTMD) - PREM14A SEC Filings 02/11/2022
Haymaker Acquisition Corp. III (BTMD) - DEFA14A SEC Filings 01/13/2022
Haymaker Acquisition Corp. III (BTMD) - DEFA14A SEC Filings 12/14/2021
Haymaker Acquisition Corp. III (BTMD) - 8-K/A - Current report SEC Filings 12/14/2021
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 12/14/2021
Haymaker Acquisition Corp. III (BTMD) - DEFA14A SEC Filings 12/13/2021
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 12/13/2021
Haymaker Acquisition Corp. III (BTMD) - 10-Q/A - Quarterly Report SEC Filings 11/29/2021
Haymaker Acquisition Corp. III (BTMD) - 10-Q - Quarterly Report SEC Filings 11/24/2021
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 11/18/2021
Haymaker Acquisition Corp. III (BTMD) - NT 10-Q - Quarterly Report SEC Filings 11/15/2021
Haymaker Acquisition Corp. III (BTMD) - 10-Q - Quarterly Report SEC Filings 08/17/2021
Haymaker Acquisition Corp. III (BTMD) - NT 10-Q - Quarterly Report SEC Filings 08/16/2021
Haymaker Acquisition Corp. III (BTMD) - 10-Q - Quarterly Report SEC Filings 05/20/2021
Haymaker Acquisition Corp. III (BTMD) - NT 10-Q - Quarterly Report SEC Filings 05/17/2021
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 05/17/2021
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 04/19/2021
Haymaker Acquisition Corp. III (BTMD) - SC 13G SEC Filings 03/11/2021
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 03/11/2021
Haymaker Acquisition Corp. III (BTMD) - 4 SEC Filings 03/09/2021
Haymaker Acquisition Corp. III (BTMD) - 8-K - Current report SEC Filings 03/05/2021
Haymaker Acquisition Corp. III (BTMD) - 424B4 SEC Filings 03/03/2021
Haymaker Acquisition Corp. III (BTMD) - EFFECT SEC Filings 03/02/2021
Haymaker Acquisition Corp. III (BTMD) - CERT SEC Filings 03/01/2021
Haymaker Acquisition Corp. III (BTMD) - 3 SEC Filings 03/01/2021
Haymaker Acquisition Corp. III (BTMD) - 8-A12B SEC Filings 02/26/2021
Haymaker Acquisition Corp. III (BTMD) - CORRESP SEC Filings 02/25/2021
Haymaker Acquisition Corp. III (BTMD) - S-1/A SEC Filings 02/22/2021
Haymaker Acquisition Corp. III (BTMD) - S-1 SEC Filings 02/12/2021
Haymaker Acquisition Corp. III (BTMD) - CORRESP SEC Filings 02/11/2021
Haymaker Acquisition Corp. III (BTMD) - UPLOAD SEC Filings 02/10/2021
Haymaker Acquisition Corp. III (BTMD) - DRS/A SEC Filings 01/25/2021
Haymaker Acquisition Corp. III (BTMD) - DRS SEC Filings 08/06/2020

Press Releases

StockPrice Release
Biote reports first quarter 2024 financial results 05/07/2024
Biote announces definitive settlement with founder 04/29/2024
Biote schedules first quarter 2024 financial results release and conference call 04/23/2024
Biote reports fourth quarter and full year 2023 financial results 03/12/2024
Biote announces $20 million share repurchase authorization 01/25/2024
Biote to purchase asteria health 01/17/2024
Biote provides preliminary 2023 results and initial 2024 guidance 01/17/2024
Biote names robert peterson as chief financial officer 01/11/2024
Biote reports third quarter 2023 financial results 11/07/2023
Biote schedules third quarter 2023 financial results release and conference call 10/24/2023
Biote reports second quarter 2023 financial results 08/10/2023
Biote schedules second quarter 2023 financial results release and conference call 07/27/2023
Biote formalizes commitment to men's hormone health with launch of new men's health division 06/22/2023
Biote announces expiration and results of exchange offer and consent solicitation relating to warrants 06/08/2023
Biote reports first quarter 2023 financial results 05/09/2023
Biote schedules first quarter 2023 financial results release and conference call 04/26/2023
Biote names john denne as general manager, men's health division 04/10/2023
Biote reports fourth quarter and full year 2022 financial results 03/28/2023
Study: testosterone pellet therapy significantly improves bone density in male patient case report 03/27/2023
Biote schedules fourth quarter and full year 2022 financial results release and conference call 02/09/2023
Biote announces closing of secondary offering of 8,500,000 shares of common stock including full exercise of the underwriters' over-allotment option 01/09/2023
Biote announces pricing of secondary offering of common stock 01/05/2023
Biote reports third quarter financial results 11/08/2022
Biote appoints debby morris to board of directors 11/07/2022
Biote schedules third quarter 2022 financial results release and conference call 10/31/2022
Biote releases updated corporate presentation for october 2022 10/10/2022
Biote announces strategic partnership with imac holdings, inc. 09/07/2022
Biote announces approval to relist on the nasdaq stock market 08/25/2022
Biote issues correction to second quarter operating loss and net income 08/15/2022
Biote reports second quarter 2022 financial results 08/09/2022
Biote to report second quarter 2022 financial results on august 9, 2022 and host conference call on august 10, 2022 07/20/2022
Biote appoints ross w. mcquivey, m.d. 06/16/2022
Biote announces participation in the jefferies healthcare conference 2022 06/06/2022
National women in the workplace survey: women with menopausal symptoms suffer in silence in the workplace 06/06/2022

More Headlines

News
biote Corp. (BTMD) Q4 2023 Earnings Call Transcript biote Corp. (BTMD) Q4 2023 Earnings Call Transcript 03/12/2024
Biote Reports Fourth Quarter and Full Year 2023 Financial Results IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Financial Highlights (All financial result comparisons made are against the prior-year period) Revenue of $45.7 million, a 2.7% increase and in line with pre-released financial guidance Proc. 03/12/2024
Analysts Estimate biote Corp. (BTMD) to Report a Decline in Earnings: What to Look Out for Biote Corp. (BTMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. 03/05/2024
Biote Announces $20 Million Share Repurchase Authorization IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that its Board of Directors has approved a $20 million share repurchase program of the Company's common stock. This approval grants Biote's management the authority to repurchase outstanding shares of the Company's common stock, from time to time, in the op. 01/25/2024
Biote Provides Preliminary 2023 Results and Initial 2024 Guidance IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that management expects 2023 revenue and Adjusted EBITDA to be slightly below prior guidance. The Company had previously forecast that revenue and Adjusted EBITDA would be toward the lower end of the previously announced ranges of $190-$200 million and $56-. 01/17/2024
Biote to Purchase Asteria Health IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced a definitive agreement to acquire F.H. Investments, Inc., d/b/a Asteria Health, a privately held 503B manufacturer of compounded bioidentical hormones. The company operates an FDA-registered 503B outsourcing facility in Birmingham, Alabama and currently sup. 01/17/2024
Biote Names Robert Peterson as Chief Financial Officer IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that Robert Peterson has been named Chief Financial Officer, effective January 8, 2024. Mr. Peterson will lead Biote's finance operations, including accounting and controllership, financial planning and analysis, financial reporting, internal audit, tax, tr. 01/11/2024
biote Should Keep Delivering Strong Growth biote Corp. returned to profitability in Q3 2023 and is expected to continue to be profitable in the future. The company's growth is driven by the sale of hormone replacement therapy products and its expansion into complementary wellness products. BTMD is considered undervalued and has an aggressive price target for the end of next year. 11/29/2023
Biote Corp. (BTMD) Reports Q3 Loss, Lags Revenue Estimates Biote Corp. (BTMD) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of $0.08. This compares to loss of $0.09 per share a year ago. 11/07/2023
Biote Reports Third Quarter 2023 Financial Results IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy, today announced financial results for the third quarter ended September 30, 2023. Third Quarter 2023 Financial Highlights (All financial result comparisons made are against the prior year period) Revenue of $45.6 million, an 8.5% increase Gross profit margin of 68.9%, a 70-basis point increase Net income of $19.6 million, representing. 11/07/2023
Biote Schedules Third Quarter 2023 Financial Results Release and Conference Call IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading provider of hormone optimization, today announced the Company will provide third quarter financial results on Tuesday, November 7, 2023, after the close of the market. A conference call to discuss the firm's results will be held Wednesday, November 8, 2023, at 8:30 a.m. ET. Conference Call Details The conference call may be accessed by dialing (844) 481-2820 (U.S toll-free) or (412) 317-0679 (Intern. 10/24/2023
Biote Corp. (BTMD) Beats Q2 Earnings and Revenue Estimates Biote Corp. (BTMD) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.27 per share a year ago. 08/10/2023
Biote Reports Second Quarter 2023 Financial Results IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy, today announced financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Financial Highlights (All financial result comparisons made are against the prior year period) Revenue of $49.3 million, a 19.1% increase Gross profit margin of 67.9%, a 60-basis point increase Net loss of $(13.1) million and GAAP loss pe. 08/10/2023
Recent Price Trend in biote Corp. (BTMD) is Your Friend, Here's Why If you are looking for stocks that are well positioned to maintain their recent uptrend, biote Corp. (BTMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen. 07/18/2023
biote Corp. (BTMD) Moves 5.3% Higher: Will This Strength Last? biote Corp. (BTMD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term. 07/12/2023
Biote Schedules First Quarter 2023 Financial Results Release and Conference Call IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading provider of preventive health care through the delivery of personalized hormone therapy, today announced the Company will provide first quarter financial results on Tuesday, May 9, 2023, after the close of the market. A conference call to discuss the firm's results will be held Wednesday, May 10, 2023, at 8:30 a.m. ET. Conference Call Details The conference call may be accessed by dialing (844) 481-. 04/26/2023
Does biote Corp. (BTMD) Have the Potential to Rally 82.51% as Wall Street Analysts Expect? The mean of analysts' price targets for biote Corp. (BTMD) points to an 82.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. 03/31/2023
Biote Schedules Fourth Quarter and Full Year 2022 Financial Results Release and Conference Call IRVING, Texas--(BUSINESS WIRE)--Biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading provider of preventive health care through the delivery of personalized hormone therapy, today announced the Company will provide fourth quarter and full year financial results on Tuesday, March 28, 2023, after the close of the market. A conference call to discuss the firm's results will be held Wednesday, March 29, 2023 at 8:30 a.m. ET. 02/09/2023
Biote Schedules Third Quarter 2022 Financial Results Release and Conference Call IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading provider of preventive health care through the delivery of personalized hormone therapy, today announced the Company will provide third quarter financial results on Tuesday, November 8, 2022, after the close of the market. 10/31/2022
Biote to Report Second Quarter 2022 Financial Results on August 9, 2022 and Host Conference Call on August 10, 2022 IRVING, Texas--(BUSINESS WIRE)--biote Corp. (“Biote” or the “Company”) (Nasdaq: BTMD), a high growth, medical practice-building business within the hormone optimization space, will report its financial results for the second quarter ended June 30, 2022, after market close on Tuesday, August 9, 2022. Terry Weber, Chief Executive Officer, and the Company's management will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET on Wednesday, August 10 07/20/2022

Unlock

BTMD Ratings Summary

BTMD Quant Ranking